FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010961805> ?p ?o ?g. }

• W3010961805 abstract "Growing concerns about the waning efficacy of IPTp-SP warrants continuous monitoring and evaluation. This study determined coverage of IPTp-SP and compared the effectiveness of the 3-dose to 2-dose regimen on placental malaria (PM) infection and low birth weight (LBW) in the Mount Cameroon area.Consenting pregnant women were enrolled consecutively through a cross-sectional survey at delivery at four antenatal clinics, two each from semi-rural and semi-urban settings from November 2016 to December 2017. Reported IPTp-SP use, demographic and antenatal clinic (ANC) data of the mothers and neonate birth weights were documented. Maternal haemoglobin concentration was measured using a haemoglobinometer and PM infection diagnosed by placental blood microscopy. Logistic regression analysis was used to model study outcomes.Among the 465 parturient women enrolled, 47.0% (203), 34.7% (150), 18.3% (79) and 7.1% (33) reported uptake of ≥ 3, 2.1 dose(s) and no SP, respectively. Uptake of ≥ 3 doses varied significantly (p < 0.001) according to type of medical facility, timing of ANC initiation and number of ANC visits. The prevalence of PM was 18.5% where uptake of ≥ 3 SP doses (AOR = 2.36: 95% CI 1.41-4.87), primiparity (AOR = 2.13: 95% CI 1.19-3.81), semi-rural setting (AOR = 1.85: 95% CI 1.12-3.04) increased odds of infection. Also, three or more dosing was associated (p < 0.001) with increased PM density notably among women from semi-urban areas. Compared with third trimester, ANC initiation in the second trimester (AOR: 0.39: 95% CI 0.20-0.74) lower odds of infection. The prevalence of LBW infants was 7.3% and were generally those of anaemic (AOR: 4.6: 95% CI 1.03-20.57) and semi-rural (AOR: 5.29: 95% CI 1.73-16.15) women. Although ≥ 3 (AOR: 0.31: 95% CI 0.11-0.87) and 2 (AOR: 0.32: 95% CI 0.11-0.93) doses of SP was associated with lower odds of LBW, ≥ 3 doses were not associated with additional increase in birth weight nor maternal haemoglobin levels when compared with 2 doses.In the Mount Cameroon area, reported uptake of IPTp with ≥ 3 SP doses did not provide observable prophylactic benefits. SP resistance efficacy studies are necessary." @default.
• W3010961805 created "2020-03-23" @default.
• W3010961805 creator A5009137415 @default.
• W3010961805 creator A5026344445 @default.
• W3010961805 creator A5037036664 @default.
• W3010961805 creator A5065026642 @default.
• W3010961805 creator A5070962424 @default.
• W3010961805 creator A5074888442 @default.
• W3010961805 creator A5074895512 @default.
• W3010961805 creator A5086578886 @default.
• W3010961805 creator A5087552412 @default.
• W3010961805 date "2020-03-02" @default.
• W3010961805 modified "2023-10-16" @default.
• W3010961805 title "Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon" @default.
• W3010961805 cites W1532912772 @default.
• W3010961805 cites W1548636822 @default.
• W3010961805 cites W1808142626 @default.
• W3010961805 cites W1919094272 @default.
• W3010961805 cites W1947887788 @default.
• W3010961805 cites W1969763842 @default.
• W3010961805 cites W1996551849 @default.
• W3010961805 cites W2003360600 @default.
• W3010961805 cites W2005653369 @default.
• W3010961805 cites W2016712838 @default.
• W3010961805 cites W2019358007 @default.
• W3010961805 cites W2044582839 @default.
• W3010961805 cites W2080860763 @default.
• W3010961805 cites W2095396004 @default.
• W3010961805 cites W2098282098 @default.
• W3010961805 cites W2106552226 @default.
• W3010961805 cites W2107150651 @default.
• W3010961805 cites W2108741937 @default.
• W3010961805 cites W2110530691 @default.
• W3010961805 cites W2122335316 @default.
• W3010961805 cites W2127377452 @default.
• W3010961805 cites W2134522413 @default.
• W3010961805 cites W2138255286 @default.
• W3010961805 cites W2141917084 @default.
• W3010961805 cites W2145260697 @default.
• W3010961805 cites W2159563738 @default.
• W3010961805 cites W2162666157 @default.
• W3010961805 cites W2166773458 @default.
• W3010961805 cites W2176397058 @default.
• W3010961805 cites W2178746032 @default.
• W3010961805 cites W2261402810 @default.
• W3010961805 cites W2301537884 @default.
• W3010961805 cites W2310319955 @default.
• W3010961805 cites W2465926223 @default.
• W3010961805 cites W2522236187 @default.
• W3010961805 cites W2523051558 @default.
• W3010961805 cites W2540523027 @default.
• W3010961805 cites W2561035331 @default.
• W3010961805 cites W2575925300 @default.
• W3010961805 cites W2579561924 @default.
• W3010961805 cites W2588945879 @default.
• W3010961805 cites W2593167305 @default.
• W3010961805 cites W2593801067 @default.
• W3010961805 cites W2601859644 @default.
• W3010961805 cites W2742678565 @default.
• W3010961805 cites W2749244569 @default.
• W3010961805 cites W2785708411 @default.
• W3010961805 cites W2786033909 @default.
• W3010961805 cites W2791363654 @default.
• W3010961805 cites W2942899143 @default.
• W3010961805 doi "https://doi.org/10.1186/s12936-020-03155-2" @default.
• W3010961805 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7053117" @default.
• W3010961805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32122339" @default.
• W3010961805 hasPublicationYear "2020" @default.
• W3010961805 type Work @default.
• W3010961805 sameAs 3010961805 @default.
• W3010961805 citedByCount "13" @default.
• W3010961805 countsByYear W30109618052021 @default.
• W3010961805 countsByYear W30109618052022 @default.
• W3010961805 countsByYear W30109618052023 @default.
• W3010961805 crossrefType "journal-article" @default.
• W3010961805 hasAuthorship W3010961805A5009137415 @default.
• W3010961805 hasAuthorship W3010961805A5026344445 @default.
• W3010961805 hasAuthorship W3010961805A5037036664 @default.
• W3010961805 hasAuthorship W3010961805A5065026642 @default.
• W3010961805 hasAuthorship W3010961805A5070962424 @default.
• W3010961805 hasAuthorship W3010961805A5074888442 @default.
• W3010961805 hasAuthorship W3010961805A5074895512 @default.
• W3010961805 hasAuthorship W3010961805A5086578886 @default.
• W3010961805 hasAuthorship W3010961805A5087552412 @default.
• W3010961805 hasBestOaLocation W30109618051 @default.
• W3010961805 hasConcept C126322002 @default.
• W3010961805 hasConcept C131872663 @default.
• W3010961805 hasConcept C142724271 @default.
• W3010961805 hasConcept C151956035 @default.
• W3010961805 hasConcept C156957248 @default.
• W3010961805 hasConcept C185032368 @default.
• W3010961805 hasConcept C187212893 @default.
• W3010961805 hasConcept C197934379 @default.
• W3010961805 hasConcept C203014093 @default.
• W3010961805 hasConcept C2777035104 @default.
• W3010961805 hasConcept C2778048844 @default.
• W3010961805 hasConcept C2778301690 @default.
• W3010961805 hasConcept C2778371730 @default.
• W3010961805 hasConcept C2779083892 @default.
• W3010961805 hasConcept C2779234561 @default.

• next